No pharmacokinetic studies have been carried out in children.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Non-severe infections |
|---|
|
| Moderately severe infections |
|---|
|
| Secondary prophylaxis for group A streptococci in patients with acute rheumatism |
|---|
|
| Prophylaxis for infection in sickle cell anaemia/asplenia |
|---|
|
| Prophylaxis for Streptococcus viridans infection in the treatment of AML with high doses of cytarabine |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Hypersensitivity reactions such as exanthema, purpura and urticaria. Nausea, vomiting, diarrhoea, hyperkalaemia.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
The suspension should not be used in children with phenylketonuria because it contains aspartame or with fructose intolerance because of the presence of sorbitol.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
The syrup should not be used in children with phenylketonuria because it contains aspartame. High doses of penicillin can create abnormalities in the blood count.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Penicillins with extended spectrum | ||
|---|---|---|
| J01CA04 | ||
| J01CA01 | ||
| J01CA11 | ||
| J01CA08 | ||
| Beta-lactamase sensitive penicillins | ||
|---|---|---|
| J01CE08 | ||
| J01CE01 | ||
| J01CE02 | ||
| J01CE10 | ||
| Beta-lactamase resistant penicillins | ||
|---|---|---|
| J01CF01 | ||
| J01CF05 | ||
| J01CF02 | ||
| J01CF02 | ||
| Combinations of penicillins, incl. beta-lactamase inhibitors | ||
|---|---|---|
| J01CR02 | ||
| J01CR01, J01CR04 | ||
| J01CR05 | ||
| J01CR04 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.